In March 2025, the company introduced new options for a immediate-to-buyer providing of its Wegovy weight loss drug. The company recognized a completely new pharmacy, referred to as NovoCare, which might charge shoppers $499 monthly for access to the drug, lower than half the expense of the drug by means of other pharmaceutical distribution network